Azenta, Inc. (NASDAQ:AZTA) Shares Sold by Bank of New York Mellon Corp

Bank of New York Mellon Corp lowered its stake in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 10.2% during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 355,308 shares of the company's stock after selling 40,438 shares during the quarter. Bank of New York Mellon Corp owned approximately 0.78% of Azenta worth $12,308,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. KLP Kapitalforvaltning AS purchased a new position in shares of Azenta during the 4th quarter worth $530,000. Deutsche Bank AG lifted its stake in shares of Azenta by 28.5% during the 4th quarter. Deutsche Bank AG now owns 4,199 shares of the company's stock worth $210,000 after purchasing an additional 931 shares during the period. Thrivent Financial for Lutherans lifted its stake in shares of Azenta by 206.5% during the 4th quarter. Thrivent Financial for Lutherans now owns 35,223 shares of the company's stock worth $1,761,000 after purchasing an additional 23,731 shares during the period. SG Americas Securities LLC lifted its stake in shares of Azenta by 90.6% during the 1st quarter. SG Americas Securities LLC now owns 30,972 shares of the company's stock worth $1,073,000 after purchasing an additional 14,719 shares during the period. Finally, Corient Private Wealth LLC lifted its stake in shares of Azenta by 12.7% during the 4th quarter. Corient Private Wealth LLC now owns 28,505 shares of the company's stock worth $1,425,000 after purchasing an additional 3,221 shares during the period. Hedge funds and other institutional investors own 99.08% of the company's stock.

Azenta Stock Down 1.5%

Shares of AZTA stock traded down $0.52 on Thursday, reaching $33.96. 509,135 shares of the stock were exchanged, compared to its average volume of 972,295. The stock has a market cap of $1.55 billion, a P/E ratio of -24.43 and a beta of 1.64. The firm has a 50 day moving average of $30.06 and a two-hundred day moving average of $36.18. Azenta, Inc. has a 1-year low of $23.91 and a 1-year high of $63.58.

Azenta (NASDAQ:AZTA - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.05 EPS for the quarter, missing analysts' consensus estimates of $0.09 by ($0.04). Azenta had a positive return on equity of 1.30% and a negative net margin of 10.31%. The firm's revenue was up 5.1% compared to the same quarter last year. During the same period last year, the firm posted $0.06 EPS. On average, equities research analysts predict that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have weighed in on the company. Evercore ISI increased their price target on Azenta from $29.00 to $35.00 and gave the stock an "in-line" rating in a research note on Tuesday, July 8th. Stephens upgraded Azenta to a "hold" rating and set a $35.00 price objective for the company in a report on Tuesday. Finally, Needham & Company LLC dropped their price objective on Azenta from $59.00 to $40.00 and set a "buy" rating for the company in a report on Wednesday, May 7th.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.